DrugPatentWatch Database Preview
Profile for Denmark Patent: 2340029
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Denmark Patent: 2340029
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 10, 2031 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
Start Trial | Apr 10, 2031 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
Start Trial | Sep 10, 2029 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
Start Trial | Sep 10, 2029 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
Start Trial | Sep 10, 2029 | Abbvie Inc | TECHNIVIE | ombitasvir; paritaprevir; ritonavir |
Start Trial | Oct 10, 2031 | Abbvie Inc | TECHNIVIE | ombitasvir; paritaprevir; ritonavir |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |